
Al-Modawat hires Deloitte for financial due diligence, a procedural step toward transferring its listing from Nomu to TASI. The move signals management is pursuing the main market upgrade now, not deferring it.
Al-Modawat Specialized Medical Co. signed an engagement letter with Deloitte & Touche LLP to provide financial due diligence services. The move is a procedural step toward transferring the company's listing from the Nomu Parallel Market to the main Saudi Exchange (TASI).
A transfer from Nomu to TASI requires the Saudi Capital Market Authority (CMA) to approve a prospectus backed by audited financials and a due diligence report from a recognized firm. Deloitte's engagement fills that requirement. For Al-Modawat, the appointment is the clearest signal yet that management is pursuing the upgrade in the current window rather than deferring it.
Nomu-listed companies face lighter disclosure and governance rules than TASI-listed peers. A transfer forces the company to meet TASI's stricter standards on financial reporting, board composition, and shareholder communications. Deloitte's work will identify gaps between Al-Modawat's current practices and TASI's requirements. The due diligence scope likely covers revenue recognition, related-party transactions, and working capital adequacy – the three areas where Nomu-to-TASI transfers most often stall.
Deloitte will produce a report that the CMA uses to assess whether Al-Modawat meets the listing rules for the main market. The key thresholds include:
Al-Modawat's financials will be tested against each of these. If Deloitte flags a deficiency, the company must either remediate it before filing or withdraw the application. The engagement letter does not guarantee a successful transfer; it only starts the verification process.
TASI-listed healthcare companies trade at a premium to their Nomu counterparts because of higher liquidity and index inclusion eligibility. A successful transfer would allow Al-Modawat to be included in the Tadawul All Share Index (TASI), which passive funds track. That index inclusion alone can drive incremental buying from ETFs and institutional mandates that cannot hold Nomu stocks.
For Al-Modawat, the valuation gap is the incentive. The company's current Nomu listing limits its investor base to Saudi retail and a handful of specialist funds. A TASI listing opens the door to foreign institutional investors, pension funds, and index-linked capital.
The engagement letter does not specify a deadline for Deloitte's work. Due diligence on a healthcare company with multiple revenue streams – insurance contracts, direct patient payments, government contracts – can take three to six months. If Deloitte identifies material issues, the timeline extends further.
Al-Modawat must also file a formal transfer application with the CMA after receiving Deloitte's report. The CMA then has up to 45 business days to review the application. The total timeline from today to a TASI listing is at least six months, assuming no delays.
The next concrete marker is the completion of Deloitte's due diligence report. Al-Modawat will disclose the outcome in a filing, either confirming no material issues or flagging required adjustments. If the report is clean, the stock's re-rating narrative gains credibility. If Deloitte identifies problems, the transfer timeline slips and the valuation premium remains out of reach.
For traders tracking Saudi healthcare listings, Al-Modawat's engagement with Deloitte is the first verifiable step in a process that could reshape the stock's liquidity profile. The watchlist question is whether the company can clear the due diligence without a capital restructuring or a governance overhaul.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.